Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
09/18/2014 | US20140274997 Cephalosporin pharmaceutical compositions |
09/18/2014 | US20140274996 Tazobactam and ceftolozane antibiotic compositions |
09/18/2014 | US20140274995 Parenteral ceftolozane antibiotic compositions |
09/18/2014 | US20140274994 Stabilizing ceftolozane |
09/18/2014 | US20140274993 Ceftolozane-tazobactam pharmaceutical compositions |
09/18/2014 | US20140274992 Ceftolozane pharmaceutical compositions |
09/18/2014 | US20140274991 Ceftolozane pharmaceutical compositions |
09/18/2014 | US20140274990 Ceftolozane pharmaceutical compositions |
09/18/2014 | US20140274989 Manufacturing beta-lactam combination products |
09/18/2014 | US20140274987 Transmucosal hormone delivery system |
09/18/2014 | US20140274986 Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same |
09/18/2014 | US20140274985 Systemic administration of androgen in treating dry eye syndrome |
09/18/2014 | US20140274982 Topical compositions of flunisolide and methods of treatment |
09/18/2014 | US20140274981 Pharmaceutical composition of s-ketamine hydrochloride |
09/18/2014 | US20140274980 Compound |
09/18/2014 | US20140274979 Method for the treatment of fatty liver disease |
09/18/2014 | US20140274978 Phytosterol spirostane and spirostene derivatives having a wide variety of utilities in humans and other animals |
09/18/2014 | US20140274977 Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease |
09/18/2014 | US20140274976 Compositions and methods for treating severe thrombocytopenia and related disease |
09/18/2014 | US20140274975 Method of determining prior history of ischemic stroke for current risk evaluation and therapy guidance |
09/18/2014 | US20140274973 Aromatic carboxylic acids in combination with aromatic hydroxyamides for inactivating non-enveloped viruses |
09/18/2014 | US20140274972 Compositions and Methods employing Wolbachia FtsZ as a target for Albendazole sulfone |
09/18/2014 | US20140274970 Controlled Release Pharmaceutical Dosage Forms |
09/18/2014 | US20140274969 Use of minocycline for therapeutic treatment of acute spinal cord injuries |
09/18/2014 | US20140274968 Omega-3 phospholipid supplements for improved brain maturity |
09/18/2014 | US20140274966 Drink Product Containing Genistein and Use Thereof |
09/18/2014 | US20140274965 Drink Product and Use Thereof |
09/18/2014 | US20140274964 Combination therapies for treatment of laminopathies, cellular aging, and atherosclerosis |
09/18/2014 | US20140274962 Methods of inhibiting presbyopia |
09/18/2014 | US20140274958 Cephalosporin compositions and methods of manufacture |
09/18/2014 | US20140274957 Methods and compositions for correction of organ dysfunction |
09/18/2014 | US20140274956 Lipidomics of familial longevity |
09/18/2014 | US20140274955 Prochelators as broad-spectrum antimicrobial agents and methods of use |
09/18/2014 | US20140274949 Personal care compositions |
09/18/2014 | US20140274948 Racecadotril liquid compositions |
09/18/2014 | US20140274947 Cyclodextrin-based polymers for therapeutic delivery |
09/18/2014 | US20140274946 Method of using nutritional compounds dihydroquercetin (taxifolin) and arabinogalactan in combination with dihydroquercetin (taxifolin) to reduce and control cardiometabolic risk factors associated with metabolic syndrome and hypercholesterolemia |
09/18/2014 | US20140274945 Resorbable Oxidized Cellulose Embolization Microspheres |
09/18/2014 | US20140274944 Sprayable Hemostat Using Soluble Oxidized Cellulose With Miniaturized Electrospray System And Method |
09/18/2014 | US20140274943 Medicinal cream made using silver sulphadiazine and chitosan and a process to make it |
09/18/2014 | US20140274939 Combined systemic and topical treatment of disordered tissues |
09/18/2014 | US20140274938 Improving recognition |
09/18/2014 | US20140274937 Methods of treating hematologic cancers |
09/18/2014 | US20140274935 Methods for determining viral sensitivity to viral inhibitors |
09/18/2014 | US20140274934 Methods for treating hcv |
09/18/2014 | US20140274933 Phthalazinone compounds and methods for the treatment of cystic fibrosis |
09/18/2014 | US20140274931 Novel compound contained in manuka honey and use of same |
09/18/2014 | US20140274929 Stealth Polymeric Particles For Delivery Of Bioactive Or Diagnostic Agents |
09/18/2014 | US20140274926 Compounds and compositions for the treatment of parasitic diseases |
09/18/2014 | US20140274924 Concentrated aqueous azalide formulations |
09/18/2014 | US20140274922 Algal omega 7 compositions |
09/18/2014 | US20140274919 Boron-containing compositions and methods therefor |
09/18/2014 | US20140274913 Methods for treating inflammation, autoimmune disorders and pain |
09/18/2014 | US20140274905 Methods and compounds for calcium ion channel regulation |
09/18/2014 | US20140274898 Hair growth methods using fgfr3 extracellular domains |
09/18/2014 | US20140274896 Transient Protection of Hematopoietic Stem and Progenitor Cells Against Ionizing Radiation |
09/18/2014 | US20140274890 Treatment for diabetes in patients inappropriate for metformin therapy |
09/18/2014 | US20140274889 Cardio- and renoprotective antidiabetic therapy |
09/18/2014 | US20140274881 Biodegradable therapeutic nanoparticles containing an antimicrobial agent |
09/18/2014 | US20140274877 Hydrochloride salts of an antibiotic compound |
09/18/2014 | US20140274875 Hemostatic Compositions And Methods |
09/18/2014 | US20140274872 Compositions and treatments based on cadherin modulation |
09/18/2014 | US20140272100 Processes for coating a carrier with microparticles |
09/18/2014 | US20140271955 Compounds and methods for inducing chondrogenesis |
09/18/2014 | US20140271946 Modifying taste and sensory irritation of smokeless tobacco and non-tobacco products |
09/18/2014 | US20140271945 Immunoassay of s-adenosylmethionine using analogs thereof and personalized therapeutics |
09/18/2014 | US20140271944 Compositions for Alleviating Inflammation and Oxidative Stress in a Mammal |
09/18/2014 | US20140271933 Universal Potent Healing Tonic |
09/18/2014 | US20140271931 Anti-Acne Topical Films |
09/18/2014 | US20140271929 Citrate containing beverage |
09/18/2014 | US20140271927 Composition and method for treating neuropathy |
09/18/2014 | US20140271926 Methods of use of glutamine synthetase inhibitors |
09/18/2014 | US20140271923 Compositions & formulations for preventing and treating chronic diseases that cluster in patients such as cardiovascular disease, diabetes, obesity, polycystic ovary syndrome, hyperlipidemia and hypertension, as well as for preventing and treating other diseases and conditions |
09/18/2014 | US20140271922 Pirenzepine as an agent in cancer treatment |
09/18/2014 | US20140271921 Pharmaceutical composition |
09/18/2014 | US20140271920 Skin ointment formulation |
09/18/2014 | US20140271918 Tannin formulation for treating gastrointestinal spasms triggered by stress |
09/18/2014 | US20140271915 Use of derivatives containing c-o-p bonds in patients with kidney failure |
09/18/2014 | US20140271914 Bone graft materials containing calcium phosphate and chitosan |
09/18/2014 | US20140271908 Dietary supplements and methods for preventing and treating migraines |
09/18/2014 | US20140271907 Compositions comprising eicosapentaenoic acid and krill oil and methods of use thereof |
09/18/2014 | US20140271906 Ngna compositions and methods of use |
09/18/2014 | US20140271903 Use of thermo-sensitive gel for controlled delivery of alk-5 inhibitors to the eye and related methods |
09/18/2014 | US20140271902 Particulate hyaluronic acid formulations for cellular delivery of bioactive agents |
09/18/2014 | US20140271898 Abuse deterrent compositions and methods of use |
09/18/2014 | US20140271897 Compositions, methods and devices for local drug delivery |
09/18/2014 | US20140271896 Tamper resistant pharmaceutical formulations |
09/18/2014 | US20140271895 Polymorph Compositions, Methods of Making, and Uses Thereof |
09/18/2014 | US20140271893 Coated phenylephrine particles and use thereof in pharmaceutical formulations |
09/18/2014 | US20140271887 Antiemetic extended release solid dosage forms |
09/18/2014 | US20140271885 Copolymers for stable micelle formulations |
09/18/2014 | US20140271884 High-loading nanoparticle-based formulation for water-insoluble steroids |
09/18/2014 | US20140271883 Curcuminoids and metabolites thereof for treating allergic nasal conditions |
09/18/2014 | US20140271882 17-hydroxyprogesterone ester containing oral compositions and related methods |
09/18/2014 | US20140271881 Antiseptic composition |
09/18/2014 | US20140271880 Fine dry particulate resveratrol active agent compositions and topical formulations including the same |
09/18/2014 | US20140271879 Fine dry particulate retinoid active agent compositions and topical formulations including the same |
09/18/2014 | US20140271876 Ophthalmic formulations |
09/18/2014 | US20140271875 Compositions including encapsulated isotretinoin and methods for use thereof |
09/18/2014 | US20140271873 Application of encapsulated capsaicin and analogues thereof for controlling calorie intake |